STAP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Despite of the low transduction efficiency, STAP-1 knockdown reduced recovered CML colony-forming cells to 89.86 ± 6.41% of control (Fig. 1c; p < 0.005).